Related Experiment Video
Updated: Jan 24, 2026

10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
15.6K
Cholesterol Binding Sites in Inwardly Rectifying Potassium Channels
1Department of Chemistry, University of Illinois at Chicago, Chicago, IL, USA. dantsker@uic.edu.
Advances in Experimental Medicine and Biology
|May 18, 2019
Summary
Cholesterol modulates inwardly rectifying potassium (Kir) channels differently. While Kir2.1 is down-regulated, Kir3.2 and Kir3.4 are up-regulated by cholesterol, despite similar binding sites.
Area of Science:
- Molecular biology
- Ion channel function
- Lipid-protein interactions
Background:
- Inwardly rectifying potassium (Kir) channels are crucial for cellular functions like membrane excitability and resting potential.
- Cholesterol is increasingly recognized as a modulator of various Kir channel subfamilies.
- Previous studies showed cholesterol down-regulates Kir2 subfamily members.
Purpose of the Study:
- To investigate the differential modulation of specific Kir channels by cholesterol.
- To compare the molecular characteristics of cholesterol binding sites in Kir2.1, Kir3.2, and Kir3.4 channels.
- To explore the implications of these differences on cholesterol's impact on ion channel activity.
Main Methods:
- Focused on three specific Kir channels: Kir2.1, Kir3.2, and Kir3.4.
- Identified putative cholesterol binding sites within transmembrane domains.
- Compared and contrasted the molecular interactions at these binding sites.
Main Results:
- Kir2.1 channel activity was down-regulated by cholesterol.
- Kir3.2 and Kir3.4 channel activities were up-regulated by cholesterol.
- Putative cholesterol binding sites were found in equivalent transmembrane domains across all three channels, but with distinct interacting residues.
Conclusions:
- Cholesterol exerts opposing effects on different Kir channel subfamilies.
- Differences in specific amino acid residues within binding sites may explain the varied responses to cholesterol.
- Understanding these molecular differences is key to comprehending cholesterol's broad impact on ion channel physiology.
Related Concept Videos
Conserved Binding Sites
5.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.1K
Conserved Binding Sites
1.9K
1.9K
Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Ligand Binding Sites
8.7K
8.7K
Antiepileptic Drugs: Potassium Channel Activators
648
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
648
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.9K

